the strength of the evidence varies widely by compound, and that is exactly why sourcing and per-batch documentation decide whether the research is worth running
Administrative claims data (20112015) from 11,351 type 2 diabetes patients who had previously been treated with metformin have recently been retrospectively analysed to compare CVD event rates following initiation of either liraglutide (66.3% of individuals), exenatide (29.6%) or other GLP-1RAs (4.1%) [35]
The math only works if the concentration on the label matches the actual concentration in the vial
The ophthalmic system, in many ways, serves as an extension of the brain
Biochem Pharmacol 39:5965 Schnleben-Janas A, Kirsch P, Mittl PR, Schirmer RH, Krauth-Siegel RL (1996) Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystalline, kinetic, and electrochemical studies